Cresco Labs (CRLBF) Profit After Tax Growth (3y) (2022 - 2026)
Cresco Labs (CRLBF) Profit After Tax Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.00 Bn | 39.35 Bn | 2.15 Bn | 14.01% |
| 3 | Zoetis | 31.59 Bn | 29.92 Bn | 1.05 Bn | -0.23% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 2.89% |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 8.71% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -34.81% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 15.37% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 36.74% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Cresco Labs | 292.94 Mn | 228.83 Mn | 86.95 Mn | 33.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.11% |
| Dec 31, 2025 | 21.03% |
| Sep 30, 2025 | -89.10% |
| Jun 30, 2025 | -54.31% |
| Mar 31, 2025 | 13.67% |
| Dec 31, 2024 | -66.72% |
| Sep 30, 2024 | 69.20% |
| Jun 30, 2024 | -177.16% |
| Mar 31, 2024 | 52.41% |
| Dec 31, 2023 | 28.43% |
| Sep 30, 2023 | -99.25% |
| Jun 30, 2023 | -44.90% |
| Mar 31, 2023 | 7.78% |
| Dec 31, 2022 | -58.67% |